PALISADE BIO, INC. — Director's Dealing 2022

Feb 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2021-11-18

Reporting Person: Trenschel Robert J. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-18	Stock Option (right to buy)	$2.32	A	48340	Acquired	2032-11-17	Common Stock (48340)	Direct

Footnotes

F1: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period.